Clinical Trials Directory

Trials / Completed

CompletedNCT02146885

The Use of Diffuse Optical Spectroscopy to Characterize in Response to Weight-Loss Intervention

The Use of Diffuse Optical Spectroscopy to Characterize Adipose Tissue Oxygenation and Vascular Reactivity in Response to Weight-Loss Intervention

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The first step in any clinical intervention against obesity involves sustained lifestyle changes. Researcher can use these strategies to beneficial the effects of weight and on cardiovascular risk. The researcher develope methods for assessing the effectiveness use optical technology to make such assessments, specifically in the area of fatty tissue can predict the effectiveness of the intervention in causing weight reduction and treating metabolic disease.

Detailed description

Optical technologies under development at the Beckman Laser Institute. Diffuse Optical Spectroscopy Imaging is a method for studying absorption and scattering (optical properties) of tissue in humans. It is related to near-infrared spectroscopy , but allows for more quantitative and thorough measurements. The researcher use Diffuse Optical Spectroscopy to measure fatty tissue, water, blood concentration level during weight loss program to determine the effect of sustained changes in weight or relapses.

Conditions

Interventions

TypeNameDescription
OTHERWeight ControlWeight Control

Timeline

Start date
2013-01-08
Primary completion
2017-01-13
Completion
2017-01-13
First posted
2014-05-26
Last updated
2022-11-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02146885. Inclusion in this directory is not an endorsement.